Navigation Links
FDA Investigating Safety of Asthma Drug Xolair
Date:7/16/2009

Injected medication may be linked to higher risk of heart attack, stroke, agency says,,

THURSDAY, July 16 (HealthDay News) -- The U.S. Food and Drug Administration has begun a safety review of the asthma drug Xolair (omalizumab) after reports of an increased risk of heart attack, abnormal heart rhythm, heart failure, and stroke, the agency said Thursday.

Early results from the Evaluating the Clinical Effectiveness and Long-Term Safety in Patients with Moderate to Severe Asthma (EXCELS) trial spurred the investigation, the FDA said. The results indicate that Xolair boosts the risk of heart problems among users of the drug compared with nonusers.

The data from the trial was supplied to the FDA by Genentech, the maker of Xolair. The trial includes some 5,000 patients taking the drug and an additional 2,500 patients who are not using Xolair, according to the FDA.

Xolair, which is given by injection, is used for those people whose asthma is not controlled by inhaled corticosteroids.

Currently, the FDA is not telling people using Xolair to stop taking the drug. However, the agency believes patients and doctors should be aware of potential problems when taking the drug, including the possible risk of heart attack and stroke.

The final results of the study are not expected until 2012, and the FDA points out that factors other than the drug could be responsible for the increase in heart attack and stroke seen among users of Xolair.

Genentech spokeswoman Tara Cooper said the preliminary study results are not sufficient to prove the drug causes increased risk of heart attack and stroke.

"Limitations of the existing data preclude a definitive association with Xolair use," Cooper said. "At this time, there is insufficient information for the companies to change their assessment of the benefit-risk profile for Xolair. Physicians should continue to assess whether Xolair is appropriate for t
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

3

GOOD

Page: 1 2

Related medicine news :

1. DEA Will Play Hardball in Investigating Michael Jacksons Doctors
2. Forensic Expert Investigating Chinese Drywall Issue
3. FDA Investigating Salmonella-Tainted Pistachios
4. Investigating a community where smoking rates are double the national average
5. Investigating causes of asthma attacks: New sensor system monitors environmental exposure
6. Micromet Receives Regulatory Approval to Conduct a Phase 2 Clinical Trial Investigating MT103 (MEDI-538) in Patients with Acute Lymphoblastic Leukemia
7. Consumer Specialty Products Association Responds to European Study Investigating Spray Products and Asthma
8. UT Southwestern investigating hypothermic technique in treating pediatric head injuries
9. CIFOR Guidelines for Foodborne Disease Outbreak Response Published by National Food Safety Group
10. American Imaging Management Debuts Patient Safety Podcasts
11. Study Evaluating Efficacy and Safety of Two Low-dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Published
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Investigating Safety of Asthma Drug Xolair  
(Date:5/25/2013)... It's not astonishing that holidays are amongst the ... endless, from family, friends and co-workers. Between the parties ... than their parents can afford, parties to arrange, and ... birthdays, anniversaries and it seems like an eternal cycle ... tired and income can’t catch up to the expenses ...
(Date:5/25/2013)... Idaho (PRWEB) May 25, 2013 A ... prevalent type of peripheral neuropathy. According to neuropathy expert ... , it is estimated that the disorder affects almost ... common complication arising from Diabetes. The high blood sugar ... Diabetes and patients suffering from it usually tend to ...
(Date:5/25/2013)... Forney, United States (PRWEB) May 25, 2013 ... oldest and largest underground shelter company in the ... and composite underground structures for over 35 years. ... of PROTECTION, U.S. Handbook of NBC Weapon Fundamentals ... is the United States’ bible on shelter engineering. ...
(Date:5/25/2013)... Pradaxa lawsuits filed on behalf ... bleeding while using the blood thinner continue to mount in ... of Illinois, Bernstein Liebhard LLP reports. According to a ... had been filed in the litigation as of ... by the Court on May 15th. ( In Re: Pradaxa ...
(Date:5/25/2013)... May 25, 2013 Many orthodontists have ... wonder where exactly that cloud is. Most people ... up with to provide their cloud service and support ... provide the service they're selling, they'd be wrong. ... (a secure, redundant facility that houses servers and ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2
... PRINCETON, N.J., Feb. 19 Medarex, Inc. (Nasdaq: ... its 2008 fourth quarter and year-end results on ... the financial markets close. Following the release, Medarex,s ... webcast at 4:30 p.m. Eastern Time. To access ...
... CVD ) today announced that it has elected ... Dr. Sheares is former chief executive officer and member of ... company that marketed a portfolio of branded cardiovascular medicines. Prior ... Health division of Merck and Co., Inc., where he led ...
... to know the least, survey finds, , , THURSDAY, Feb. 19 (HealthDay ... of a stroke and what to do if they suspect one ... research. , Older people and those who,ve already had a stroke ... the symptoms of a stroke and know to immediately call 911. ...
... PLC, a subsidiary of MGT Capital Investments, Inc. ... development of Computer-Aided Detection (CAD) and image analysis ... of disease, today announces the following restructuring of ... Rowley, currently Chief Financial Officer, becomes Chief Executive ...
... Feb. 19 A groundbreaking new survey sponsored by ... 82% of young adults aged 18-30 plan to get ... 40% of first marriages end in divorce. Why?"There is ... reality of getting or being married," says Mary Myrick, ...
... 2009 A new study released today found blacks ... replacement, an important intervention for reducing pain and improving ... study also found total knee replacements are increasing substantially ... the research underscores the need for healthcare providers and ...
Cached Medicine News:Health News:Medarex to Announce 2008 Fourth Quarter and Year-End Financial Results on Wednesday, February 25, 2009 2Health News:Covance Elects Bradley T. Sheares to Company's Board of Directors 2Health News:Know the Warning Signs of Stroke? Most Don't. 2Health News:Medicsight PLC Restructures Management Team 2Health News:Medicsight PLC Restructures Management Team 3Health News:Young People Want 'Happily Ever After,' but Lack Skills to Make Marriage Work 2Health News:New study finds blacks still lag in obtaining total knee replacements for arthritis 2Health News:New study finds blacks still lag in obtaining total knee replacements for arthritis 3
(Date:5/23/2013)... , May 23, 2013  Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...
(Date:5/23/2013)... May 23, 2013  TeamHealth Medical Call Center ... and nurse advice lines, announces its newly formed ... nursing and administrative leaders, provides clinical expertise to ... cost-effective services for hospital clients, physician clients and ... system evolves, it,s imperative to continuously advance our ...
(Date:5/23/2013)... 23, 2013  Every day, their baby stopped breathing, his ... lungs. April and Bryan Gionfriddo watched ... "Quite a few doctors said he had a ... April Gionfriddo , about her now 20-month-old son, ... work, we would take it and run with it." ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... Catalyst,Biosciences, Inc., a pioneer in the discovery and ... that it has,selected CB 813, an improved, second-generation ... candidate for the treatment of,acute bleeding in hemophilia ... protease platform technologies and know-how., CB 813 ...
... "fast track" ... drug, ... for second-round test-phase production of a,FDA-designated "fast track" drug candidate to treat ... through acts of bio-warfare,or bio-terrorism., (Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO ), ...
Cached Medicine Technology:Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia 2Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia 3Albemarle Optimizes Smallpox Drug Candidate for SIGA 2Albemarle Optimizes Smallpox Drug Candidate for SIGA 3
... is a smart, sophisticated and compact medium throughput ... effective chemistry analyser in its class! It is ... 230 tests per hour. The DataPro runs all ... normal biochemistry laboratory and runs a wide range ...
... Our manufacturing process makes ... nanocrystals ensuring magnetic responsiveness. ... with the rigid core ... magnetic aggregation occurs upon ...
... The BcMag Streptavidin magnetic beads ... capture of biotinylated molecules such ... protein from cell lysates or ... its highly dispersed, it can ...
... m Dynabeads with covalently bound ... any biotinylated target. The Dynabeads® ... area, high capacity, magnetic pull ... during incubation. The MyOne™ products ...
Medicine Products: